» Articles » PMID: 26468457

The Effects of Crocus Sativus (saffron) and Its Constituents on Nervous System: A Review

Overview
Date 2015 Oct 16
PMID 26468457
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Saffron or Crocus sativus L. (C. sativus) has been widely used as a medicinal plant to promote human health, especially in Asia. The main components of saffron are crocin, picrocrocin and safranal. The median lethal doses (LD50) of C. sativus are 200 mg/ml and 20.7 g/kg in vitro and in animal studies, respectively. Saffron has been suggested to be effective in the treatment of a wide range of disorders including coronary artery diseases, hypertension, stomach disorders, dysmenorrhea and learning and memory impairments. In addition, different studies have indicated that saffron has anti-inflammatory, anti-atherosclerotic, antigenotoxic and cytotoxic activities. Antitussive effects of stigmas and petals of C. sativus and its components, safranal and crocin have also been demonstrated. The anticonvulsant and anti-Alzheimer properties of saffron extract were shown in human and animal studies. The efficacy of C. sativus in the treatment of mild to moderate depression was also reported in clinical trial. Administration of C. sativus and its constituents increased glutamate and dopamine levels in the brain in a dose-dependent manner. It also interacts with the opioid system to reduce withdrawal syndrome. Therefore, in the present article, the effects of C. sativus and its constituents on the nervous system and the possible underlying mechanisms are reviewed. Our literature review showed that C. sativus and its components can be considered as promising agents in the treatment of nervous system disorders.

Citing Articles

Medicinal plants and plant-based traditional medicine: Alternative treatments for depression and their potential mechanisms of action.

Remali J, Aizat W Heliyon. 2024; 10(20):e38986.

PMID: 39640650 PMC: 11620067. DOI: 10.1016/j.heliyon.2024.e38986.


Molecular and Behavioral Neuroprotective Effects of Clavulanic Acid and Crocin in Haloperidol-Induced Tardive Dyskinesia in Rats.

Shoae-Hagh P, Razavi B, Sadeghnia H, Mehri S, Karimi G, Hosseinzadeh H Mol Neurobiol. 2024; 62(4):5156-5182.

PMID: 39520654 DOI: 10.1007/s12035-024-04566-x.


(Saffron): A potential multifunctional therapeutic agent for neurodegenerative disorders.

Khazdair M J Biomed Res. 2024; 39(1):114-116.

PMID: 39148255 PMC: 11873588. DOI: 10.7555/JBR.38.20240131.


and effects of crocetin and its amide derivative on acrylamide-induced neurotoxicity.

Ajzashokouhi A, Razavi B, Sadeghian H, Hosseinzadeh H Avicenna J Phytomed. 2024; 14(1):78-89.

PMID: 38948176 PMC: 11210700. DOI: 10.22038/AJP.2023.22316.


Iranian Traditional Medicine for Treatment of Attention Deficit Disorder with Hyperactivity in Children: A Systematic Review of Randomized Controlled Trials.

Noorazar S, Mirzaei M, Kalejahi P Iran J Public Health. 2024; 53(2):280-292.

PMID: 38894827 PMC: 11182478. DOI: 10.18502/ijph.v53i2.14913.


References
1.
Xuan B, Zhou Y, Li N, Min Z, Chiou G . Effects of crocin analogs on ocular blood flow and retinal function. J Ocul Pharmacol Ther. 1999; 15(2):143-52. DOI: 10.1089/jop.1999.15.143. View

2.
Abe K, Sugiura M, Yamaguchi S, Shoyama Y, Saito H . Saffron extract prevents acetaldehyde-induced inhibition of long-term potentiation in the rat dentate gyrus in vivo. Brain Res. 2000; 851(1-2):287-9. DOI: 10.1016/s0006-8993(99)02174-5. View

3.
Abe K, Saito H . Effects of saffron extract and its constituent crocin on learning behaviour and long-term potentiation. Phytother Res. 2000; 14(3):149-52. DOI: 10.1002/(sici)1099-1573(200005)14:3<149::aid-ptr665>3.0.co;2-5. View

4.
Cryan J, Lucki I . Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors. J Pharmacol Exp Ther. 2000; 295(3):1120-6. View

5.
Soeda S, Ochiai T, Paopong L, Tanaka H, Shoyama Y, Shimeno H . Crocin suppresses tumor necrosis factor-alpha-induced cell death of neuronally differentiated PC-12 cells. Life Sci. 2001; 69(24):2887-98. DOI: 10.1016/s0024-3205(01)01357-1. View